Clinical Trial Update: Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating novel immunomodulators as both monotherapy and in combination with anticancer agents for advanced hepatobiliary cancers. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Undisclosed immunomodulators

Snippet

Sponsor: AstraZeneca | Conditions: Hepatocellular Carcinoma, Biliary Tract Cancer | Phase 2 | Status: RECRUITING